PTH and osteoporosis: Teriparatide (TPTD), an N-terminal fragment of human parathyroid hormone (PTH) (1–34), is an anabolic agent for the treatment of osteoporosis [1–3] that markedly increases bone mineral density (BMD) and decreases fracture risk [4–6].